← Leaderboards
Piran Sioshansi
Radiomed Corporation
$1,855,712
Attributed
$1,855,712
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,855,712 · 4
By mechanism
R44$1,567,823 · 2
R43$287,889 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Palladium”
- John F Hartwig · University Of California Berkeley$12,202,703
- Stephen L Buchwald · Massachusetts Institute Of Technology$11,783,158
- Sergey A Kozmin · University Of Chicago$9,892,654
- Kristy Perez · Civatech Oncology, Inc.$9,817,743
- Barry M Trost · University Of California San Francisco$8,440,982
- Brian M Stoltz · California Institute Of Technology$7,409,940
Research focus
PalladiumNeoplasm /Cancer Radionuclide TherapyDrug Delivery SystemsHuman SubjectBiomedical Equipment DevelopmentClinical ResearchRadiation DosageRadiation Therapy DosageEye NeoplasmsMelanomaDrug Design /Synthesis /ProductionDoseDogsIndexingDevelopment, Computer SystemsBreast NeoplasmsDesignHeartContralateralBreastExposure ToImageExclusion CriteriaComplement
Grant awards (5)
Real-Time Image and Dose Guided Radiation Therapy System$149,964
R43 · FY2008 · CA · contact PI
CONFORMAL RADIOACTIVE PLAQUES FOR INTRAOCULAR MELANOMA$452,474
R44 · FY2001 · EY
PATIENT OPTIMIZED BRACHYTHERAPY FOR BREAST CARCINOMA$137,925
R43 · FY2001 · CA
LINEAR PD SOURCES FOR PROSTATE BRACHYTHERAPY$660,691
R44 · FY2000 · CA
CONFORMAL RADIOACTIVE PLAQUES FOR INTRAOCULAR MELANOMA$454,658
R44 · FY2000 · EY